Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2024
Programm
Poster
Suche
DE
Zurück
Poster session
PoS 1
ePoster 07
Termin
Datum:
04.12.
Zeit:
17:00
–
18:00
Ort / Stream:
ePoster station 7
Programm
ePoster
P071
Contemporary prospective understanding of migraine real-world evidence (CAPTURE): baseline clinical characteristics
Laurent Delahaye (Rungis, FR)
ePoster
P072
Difference in sensitization mechanism across low-frequency episodic, high-frequency episodic, and chronic migraine
Stefano Di Antonio (Aalborg, DK)
ePoster
P073
Comorbidity rates in a large cohort of patients with migraine – a real-world data analysis
Matanya Tirosh (Herzliya, IL)
Danna Davidovici (Herzliya, IL)
ePoster
P074
Milk and plasma pharmacokinetics of single-dose atogepant in healthy lactating women
Ramesh Boinpally (North Chicago, US)
ePoster
P075
Evidence of visual hyperexcitability during and outside of migraine attacks – a reform functional MRI study
Rune Häckert Christensen (Glostrup, DK)
ePoster
P076
Impact of Atogepant on daily functioning in patients with episodic migraine and chronic migraine: Activity Impairment in Migraine-Diary (AIM-D) Item-Level analysis
Richard B. Lipton (Bronx, US)
ePoster
P077
The impact of the migraine treatment Botulinum toxin on inflammatory and pain responses: insights from an animal model
Philip Victor Reducha (Copenhagen, DK)
ePoster
P078
Results from the 2
nd
Italian interim analysis of the PEARL study: concomitant acute medication use Over 12 months of Fremanezumab treatment
Gabriella Egeo (Rome, IT)
ePoster
P079
Differences in cortical activity in interictal, ictal, and chronic migraine
Marco Lisicki (Córdoba, AR)
ePoster
P080
Decreased intracortical inhibition in patients with hemiplegic migraine – a transcranial magnetic stimulation (TMS) study
Genevieve Demarquay (Bron, FR)
ePoster
P081
Long-term (72-week) improvement in headache frequency, severity, and burden following early headache reduction with eptinezumab for migraine prevention
Cristina Tassorelli (Pavia, IT)
ePoster
P082
Impact of Atogepant on achieving complete improvement as early as week 1 based on the Activity impairment in Migraine-Diary (AIM-D) domains: post hoc analysis from the ADVANCE, ELEVATE, and PROGRESS trials
Andreas R. Gantenbein (Bad Zurzach, CH)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz